Ghrelin therapy increased ERK activation and suppressed JNK activation in ileum, and decreased intestinal injury after radiation injury combined wound (CI) [43]; in brain haemorrhage induced by CI, Ghrelin therapy with pegylated G-CSF significantly mitigated ERK1/2 and JNK activation [44]. This evidence concerns the gene MAPK3 and intracranial hemorrhage.